The Norwegian Biotechnology Advisory Board
The Norwegian Biotechnology Advisory Board is an independent body consisting of 15 members appointed by the Norwegian government. Each member has a background and/or education which makes him/her competent to discuss questions regarding modern biotechnology. The main tasks of the Norwegian Biotechnology Advisory Board is to evaluate the social and ethical consequences of modern biotechnology and to discuss usage which promotes sustainable development.
The Norwegian Biotechnology Advisory Board has approximately ten regular board meetings and organises several public conferences annually.
The secretariat of the Norwegian Biotechnology Advisory Board has seven employees assisting and coordinating the board.
The Norwegian Biotechnology Advisory Board publishes the free, quarterly journal GENialt in Norwegian. In addition it makes background information available on various topics regarding modern biotechnology.
For further information, please contact the secretariat of the Norwegian Biotechnology Advisory Board at the phone number or address below.
Statement 4.12.2018
The Gene Technology Act – Final statement (summary)
The Gene Technology Act – Final statement (full report)
Statement 5.12.2017
The Gene Technology Act – Invitation to Public Debate (summary)
The Gene Technology Act – Invitation to Public Debate (full report)
Statement 14.2.2017
Discussion paper 2014
Herbicide-resistant genetically modified plants and sustainability
Brochure 2010
Preimplantation Genetic Diagnosis (pdf, 26.04.2010)
Discussion papers
«Gene medication or genetic modification? The devil is in the details», Foss, G.S & Rogne S.
